ITW vs SGMT · P/E 22, rev $16.04B vs rev $2.0M
Illinois Tool Works Inc (ITW) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported ITW revenue for 2025-12-31 was $16.04B. Net income was $3.07B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
ITW currently screens at market cap $72.53B and trailing P/E 21.8. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the ITW and SGMT stock pages for the full models.
Not investment advice.